Zobrazeno 1 - 10
of 201
pro vyhledávání: '"Rongcheng Luo"'
Autor:
Jun Wang, Bicheng Zhang, Ling Peng, Xiufeng Liu, Jianguo Sun, Chunxia Su, Huijuan Wang, Zheng Zhao, Lu Si, Jianchun Duan, Hongmei Zhang, Mengxia Li, Bo Zhu, Li Zhang, Jin Li, Jun Guo, Rongcheng Luo, Wensheng Qiu, Dingwei Ye, Qian Chu, Jiuwei Cui, Xiaorong Dong, Yun Fan, Quanli Gao, Ye Guo, Zhiyong He, Wenfeng Li, Gen Lin, Lian Liu, Yutao Liu, Haifeng Qin, Shengxiang Ren, Xiubao Ren, Yongsheng Wang, Junli Xue, Yunpeng Yang, Zhenzhou Yang, Lu Yue, Xianbao Zhan, Junping Zhang, Jun Ma, Shukui Qin, Baocheng Wang
Publikováno v:
Therapeutic Advances in Medical Oncology, Vol 15 (2023)
Immune checkpoint inhibitors (ICIs) targeting programmed cell death 1, programmed cell death ligand 1, and cytotoxic T lymphocyte-associated antigen-4 have shown significantly durable clinical benefits and tolerable toxicities and have improved the s
Externí odkaz:
https://doaj.org/article/f8a88d8af47240c58b608836f46066e4
Autor:
Xiaomin Zhang, Jinming Wu, Liangliang Qiao, Lixuan Chen, Chaolin Chen, Hui Zhang, Rongcheng Luo, Yang Xiao
Publikováno v:
Frontiers in Oncology, Vol 13 (2023)
Chimeric antigen receptor (CAR) T-cell therapy has emerged as a powerful immunotherapy in relapsed/refractory (R/R) hematological malignancies, especially in R/R B-cell acute lymphocytic leukemia (B-ALL), non-Hodgkin lymphoma (NHL), and multiple myel
Externí odkaz:
https://doaj.org/article/76d2254bbd6944659b02ac89caff7d45
Autor:
Jiahao Liu, Yinghao Wen, Zhen Liu, Shu Liu, Ping Xu, Yan Xu, Shuting Deng, Shulu Hu, Rongcheng Luo, Jingwen Jiang, Guifang Yu
Publikováno v:
Molecular Therapy: Nucleic Acids, Vol 23, Iss , Pp 324-335 (2021)
VPS33B is reported to be a tumor suppressor in hepatocellular carcinoma, nasopharyngeal carcinoma, colon cancer, and lung adenocarcinoma. Here, we observed that reduced VPS33B protein level was an unfavorable factor that promoted the pathogenesis of
Externí odkaz:
https://doaj.org/article/43a3e7953c984a95b2a18bad1941693d
Autor:
Chao Cheng, Wenmin Li, Xuemei Peng, Xiong Liu, Ziyan Zhang, Zhen Liu, Tongyuan Deng, Rongcheng Luo, Weiyi Fang, Xiaojie Deng
Publikováno v:
Molecular Therapy: Methods & Clinical Development, Vol 20, Iss , Pp 615-624 (2021)
Nasopharyngeal carcinoma (NPC) is one of the most common malignant tumors in Chinese and other Southeast Asians. We aimed to explore the precise mechanism for NESG1 in NPC for understanding the pathogenesis of NPC. Transwell, Boyden assays, and wound
Externí odkaz:
https://doaj.org/article/0c19c24fe87b4e97a0d960f1369616e7
Autor:
Mengyang Zhao, Rongcheng Luo, Yiyi Liu, Linyuan Gao, Zhaojian Fu, Qiaofen Fu, Xiaojun Luo, Yiyu Chen, Xiaojie Deng, Zixi Liang, Xin Li, Chao Cheng, Zhen Liu, Weiyi Fang
Publikováno v:
Nature Communications, Vol 12, Iss 1, Pp 1-3 (2021)
Externí odkaz:
https://doaj.org/article/dee656f99dc2448bb2a54372a7e4bb99
Autor:
Lijuan Meng, Yan Zhou, Sihan Ju, Jing Han, Ci Song, Jing Kong, Yifei Wu, Shuai Lu, Jiani Xu, Wenwen Yuan, Erbao Zhang, Cheng Wang, Zhibin Hu, Yayun Gu, Rongcheng Luo, Xuehao Wang
Publikováno v:
Cancer Medicine, Vol 8, Iss 14, Pp 6476-6484 (2019)
Abstract Purpose The overexpression and knockdown of PLK4 were both reported to generate aneuploidy. Thus, we aimed to investigate whether genetic variants in PLK4 contribute to the development of hepatocellular carcinoma (HCC). Methods We evaluated
Externí odkaz:
https://doaj.org/article/61b99de8bf924618b332fc77695fe369
Autor:
YuanBo Xue, Xun Lai, RuiLei Li, ChunLei Ge, BaoZhen Zeng, Zhen Li, QiaoFen Fu, LiuFang Zhao, SuWei Dong, JinYan Yang, JiYin Guo, QingYin Meng, QingHua Tan, ZhenHui Li, HaiYan Ding, YanLei Zhang, ShaoHui Liu, Alex H. Chang, Hong Yao, RongCheng Luo
Publikováno v:
Frontiers in Oncology, Vol 10 (2021)
BackgroundIn clinical applications of CAR T-cell therapy, life-threatening adverse events including cytokine release syndrome and neurotoxicity can lead to treatment failure. Outcomes of patients treated with anti-CD30 CAR T- cell have been disappoin
Externí odkaz:
https://doaj.org/article/10773d9ad59d4570bdf6971f6635786d
Autor:
Chen Liu, Xuemei Peng, Yonghao Li, Shu Liu, Rentao Hou, Yewei Zhang, Shi Zuo, Zhan Liu, Rongcheng Luo, Libo Li, Weiyi Fang
Publikováno v:
Biomedicine & Pharmacotherapy, Vol 123, Iss , Pp 109780- (2020)
FAM83A is part of an 8-member protein family of unknown function and is reported to be a cancer-promoting and treatment-resistance factor in several cancers. However, its role in hepatocellular carcinoma (HCC) remains unclear. Analysis of the Cancer
Externí odkaz:
https://doaj.org/article/27ce1e5b476c4df58ae18ad847c24ca3
Autor:
Zike Yang, Yanxia Qi, Nan Lai, Jiahe Zhang, Zehong Chen, Mingyu Liu, Wan Zhang, Rongcheng Luo, Shijun Kang
Publikováno v:
Journal of Experimental & Clinical Cancer Research, Vol 37, Iss 1, Pp 1-13 (2018)
Abstract Background The receptors of Notch family play an important role in controlling the development, differentiation, and function of multiple cell types. The aim of this study is to investigate the role of Notch1 signaling upon immune suppressio
Externí odkaz:
https://doaj.org/article/c4349407d9de42d184ab27af30fb5023
Publikováno v:
Journal of Experimental & Clinical Cancer Research, Vol 37, Iss 1, Pp 1-13 (2018)
Abstract Background The high incidence of recurrence and metastasis of hepatocellular carcinoma (HCC) necessitate the discovery of new predictive biomarkers of invasion and prognosis. Minichromosome maintenance complex component 6 (MCM6), which has b
Externí odkaz:
https://doaj.org/article/621c6a93200345b5916e83d4101510a1